RBA Wealth Management LLC Grows Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

RBA Wealth Management LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 1.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,488 shares of the healthcare conglomerate’s stock after buying an additional 131 shares during the period. UnitedHealth Group comprises about 3.3% of RBA Wealth Management LLC’s holdings, making the stock its 3rd largest position. RBA Wealth Management LLC’s holdings in UnitedHealth Group were worth $5,900,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. NorthCrest Asset Manangement LLC lifted its position in shares of UnitedHealth Group by 9.5% during the first quarter. NorthCrest Asset Manangement LLC now owns 518 shares of the healthcare conglomerate’s stock valued at $264,000 after purchasing an additional 45 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 67.7% during the first quarter. EverSource Wealth Advisors LLC now owns 2,557 shares of the healthcare conglomerate’s stock valued at $1,303,000 after purchasing an additional 1,032 shares in the last quarter. Foundations Investment Advisors LLC lifted its position in shares of UnitedHealth Group by 77.0% during the second quarter. Foundations Investment Advisors LLC now owns 20,421 shares of the healthcare conglomerate’s stock valued at $10,523,000 after purchasing an additional 8,882 shares in the last quarter. NewEdge Advisors LLC raised its position in UnitedHealth Group by 10.4% in the first quarter. NewEdge Advisors LLC now owns 125,780 shares of the healthcare conglomerate’s stock worth $64,144,000 after acquiring an additional 11,880 shares during the period. Finally, Parsec Financial Management Inc. raised its position in UnitedHealth Group by 9.9% in the second quarter. Parsec Financial Management Inc. now owns 25,594 shares of the healthcare conglomerate’s stock worth $13,146,000 after acquiring an additional 2,297 shares during the period. 87.25% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 465 shares of the business’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the completion of the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at approximately $18,866,882.82. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Stephen J. Hemsley sold 99,312 shares of the company’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total transaction of $53,059,422.24. Following the completion of the sale, the director now directly owns 787,372 shares in the company, valued at approximately $420,669,238.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total transaction of $252,202.05. Following the sale, the chief accounting officer now owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The disclosure for this sale can be found here. In the last ninety days, insiders sold 140,324 shares of company stock worth $75,086,185. 0.40% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

UNH stock opened at $521.02 on Monday. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The stock has a market cap of $487.35 billion, a PE ratio of 27.21, a P/E/G ratio of 1.63 and a beta of 0.76. The firm has a 50 day simple moving average of $529.29 and a two-hundred day simple moving average of $511.81.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, topping analysts’ consensus estimates of $5.24 by $0.33. The business had revenue of $80.33 billion during the quarter, compared to analysts’ expectations of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The business’s quarterly revenue was up 12.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $4.70 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 21.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th will be issued a $1.65 dividend. The ex-dividend date is Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.27%. UnitedHealth Group’s payout ratio is 34.46%.

Analyst Ratings Changes

Several brokerages have commented on UNH. Mizuho lifted their price objective on shares of UnitedHealth Group from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, August 10th. BMO Capital Markets lifted their price objective on shares of UnitedHealth Group from $600.00 to $610.00 in a research report on Wednesday, July 20th. SVB Leerink lifted their price objective on shares of UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research report on Monday, July 18th. Credit Suisse Group lifted their target price on shares of UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Finally, Morgan Stanley lifted their target price on shares of UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $585.65.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.